SCHEMBL17290367

SCHEMBL17290367

CSc1ccc(-c2nn(C)c(O)c2C)cc1C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 1/20 0.36
MPL P40238 2/20 0.34
NOTUM Q6P988 1/20 0.34
KCNH2 Q12809 1/20 0.33
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
ESR1 P03372 2/20 0.32
SIGMAR1 Q99720 1/20 0.31
AR P10275 1/20 0.30
GRM5 P41594 1/20 0.30
KDM4E B2RXH2 1/20 0.30
USP2 O75604 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HSD17B10 Q99714 1/20 0.30
SLC34A1 Q06495 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295220 1.00 COMT (0.36) COMTMPLNOTUMKCNH2PTGS1
SCHEMBL17290593 0.83 COMT (0.34) COMTMPLNOTUMPTGS1PTGS2
SCHEMBL17290446 0.83 GRM5 (0.34) ARGRM5ALDH1A1SLC34A1PIK3CD
SCHEMBL17290708 0.82 PIK3CD (0.35) PTGS1PTGS2ARALDH1A1HPGD
SCHEMBL17295106 0.82 PIK3CD (0.35) PTGS1PTGS2ARALDH1A1HPGD
SCHEMBL17290267 0.80 PTGS2 (0.35) PTGS1PTGS2ARGRM5ALDH1A1
SCHEMBL17290498 0.78 PIK3CD (0.38) KDM4EALDH1A1LMNAMAPTHPGD
SCHEMBL17295210 0.76 NOTUM (0.38) COMTMPLNOTUMARKDM4E
SCHEMBL17290693 0.76 NOTUM (0.38) COMTMPLNOTUMARKDM4E
SCHEMBL17290306 0.75 KIF11 (0.43) SIGMAR1GRM5KDM4EALDH1A1SLC34A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148972-B1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS INC (US) 2019-08-21 EP disclosed
US-9682938-B2 Pyrazolone derivatives as nitroxyl donors CARDIOXYL PHARMACEUTICALS, INC. (US) 2017-06-20 US disclosed
EP-3148972-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS Cardioxyl Pharmaceuticals Inc. (US) 2017-04-05 EP disclosed
WO-2015183839-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS, INC. (US) 2015-12-03 WO disclosed
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS TNNI3, PFKP, NOX5 COMT 1573/4885MPL 1687/4885NOTUM 1785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.